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Summary
In vertebrates, the arrestins are a family of four proteins that regulate the signaling and trafficking
of hundreds of different G-protein-coupled receptors (GPCRs). Arrestin homologs are also
found in insects, protochordates and nematodes. Fungi and protists have related proteins but do
not have true arrestins. Structural information is available only for free (unbound) vertebrate
arrestins, and shows that the conserved overall fold is elongated and composed of two domains,
with the core of each domain consisting of a seven-stranded  -sandwich. Two main
intramolecular interactions keep the two domains in the correct relative orientation, but both of
these interactions are destabilized in the process of receptor binding, suggesting that the
conformation of bound arrestin is quite different. As well as binding to hundreds of GPCR
subtypes, arrestins interact with other classes of membrane receptors and more than 20
surprisingly diverse types of soluble signaling protein. Arrestins thus serve as ubiquitous signaling
regulators in the cytoplasm and nucleus.
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Gene organization and evolutionary history 
The arrestin family has four members in mammals: arrestin1
(called visual or rod arrestin in some species, and previously
called S-antigen or 48 kDa protein), arrestin2 (also known as
 -arrestin or  -arrestin1), arrestin3 ( -arrestin2) and
arrestin4 (cone arrestin or X-arrestin). Structurally and func-
tionally the family can be subdivided into two subfamilies:
visual or sensory (arrestin1 and arrestin4) and non-visual
(arrestin2 and arrestin3) [1]. Fish and amphibians have a
rod arrestin, a cone arrestin and  at least one non-visual
arrestin; insects have at least two sensory arrestins and one
non-sensory arrestin (called Kurtz in Drosophila
melanogaster), whereas other invertebrates (such as
Caenorhabditis elegans) and protochordates (such as Ciona
intestinalis) have only one arrestin homolog. Chromosomal
locations and accession numbers are shown in Tables 1 and
2, respectively. 
In vertebrates, arrestins are encoded by large (13-50 kilo-
bases) genes containing 14-17 exons, some of which are only
10 nucleotides long [2,3]. This multi-exon structure appears
to be ancient, as the sole arrestin in the protochordate
C. intestinalis is encoded by 13 exons, with the positions of
nine introns corresponding to those in bovine rod arrestin
(arrestin1) [4]. The arrestin gene in C. elegans has ten exons
[5], whereas the genes in D. melanogaster are simpler,
having only three or four exons [6]. The positions of five
introns are identical in C. elegans, C. intestinalis and bovine
rod arrestin, suggesting that they were acquired by a
common ancestor gene. The exons do not correspond to
known structural elements of arrestins, which consist of two
domains and a variable carboxy-terminal tail [7-9], with one
interesting exception: one of the exons conserved from
C. elegans to mammals contains the phosphate-binding
motif homologous to a motif in ataxin-7, a protein mutated
in olivopontocerebellar atrophy with retinal degeneration
[10]. The multi-exon structure of vertebrate arrestins gives
rise to splice variants of rod arrestin and both non-visual
subtypes [11]. The short splice variant of rod arrestin lacks
most of the carboxy-terminal tail and has functional charac-
teristics distinct from the longer variant: it binds unphos-
phorylated rhodopsin [12] and has a different subcellularlocalization in rod photoreceptors. The long and short forms
of the two non-visual arrestins differ by 8 or 11 residues in
the proximal carboxy-terminal tail; the functional signifi-
cance of this is unclear [11,13].   
Ancestors of arrestin proteins probably appeared early in the
evolution of eukaryotes, before the separation of animals,
plants and  fungi. Yeast and several other species of fungi
have related proteins of the PalF family [14]. These proteins
of about 80 kDa have two approximately 150-residue regions
that are homologous to the cores of the two arrestin
domains. Three predicted proteins (accession numbers
EAS01748, EAS01749 and  YP_053990) from two species of
Ciliophora -  Paramecium tetraurelia and  Tetrahymena
thermophila - show homology with the same central part of
arrestin that has homology to PalF proteins. These proteins
and members of the PalF family lack most of the structural
features that are the hallmarks of ‘true’ arrestins, however.
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Table 1
Chromosomal locations of arrestin genes in selected species
Rod arrestin Cone arrestin Arrestin2 Arrestin3 Other arrestins
Homo sapiens 2q37.1 Proximal long arm of X 11q13 17p13
Mus musculus 7 50.0 cM* 11 45.0 cM*
Rattus norvegicus 9q35 1q32 10q24
Bos taurus 3 15q25
D. melanogaster Arrestin1, 2L; Arrestin2, 3L; Kurtz, 3R†.
A. gambiae Arrestin2, 2; Arrestin3, 3; Arrestin4, 2†.
C. elegans X
Rod arrestin is also called arrestin1; cone arrestin is also called arrestin4. *Position as indicated in the GeneBank entry for this gene. †For insect arrestins,
each protein name is followed by a chromosomal location. 
Table 2
Accession numbers for arrestin proteins from selected species
Rod arrestin Cone arrestin Arrestin2 Arrestin3 Other arrestins
H. sapiens NM_000541 AF033105 isoform A,  Isoform 1, 
NM_004041; NM_004313;
isoform B,  isoform 2, 
NM_020251 NM_199004
M. musculus BC016498 AF156979 isoform A, NM_145429
NM_177231;
isoform B, 
NM_178220
R. norvegicus NM_013023 NM_012910 NM_012911
B. taurus NM_181000 D85340 NM_174243 L14641
Sus scrofa NM_214079 NM_214345
Rana pipiens X92398 X92400
Ambystoma tigrinum AF203327 AF203328
Xenopus tropicalis NM_203742 BC094203 BC076815
Danio rerio NM_001002405 NM_201124
D. melanogaster Arrestin1, NM_057333; Arrestin2, NM_079252;
Kurtz, NM_080249
A. gambiae Arrestin1, Ay017417; Arrestin2, BK000996;
Arrestin3 (kurtz-like), BK000997;
Arrestin4, BK001417
Limulus polyphemus U08883
Loligo pealei AF393635
C. elegans NM_075782
C. intestinalis AB052669
Rod arrestin is also called arrestin1; cone arrestin is also called arrestin4.So far, no arrestin-related proteins of plant origin have
been described.    
Analysis of the phylogenetic tree of arrestins (Figure 1)
shows that vertebrate arrestins are divided into visual and
non-visual branches; the visual branch further subdivides
into rod and cone arrestins (arrestin1 and arrestin4) and the
non-visual branch into arrestin2 and arrestin3. Vertebrate
non-visual arrestins are the least diverse group. They are
closer to the invertebrate non-sensory subtypes than to any
other group (Additional data file 1). Arrestin2 has so far been
found only in mammals; it is much more abundant than
arrestin3 in mammalian cells, especially in mature neurons,
where overall non-visual arrestin expression levels are the
highest [15]. The greater homology within the arrestin2
group than among arrestin3 proteins in mammals suggests
that arrestin2 may be the latest evolutionary addition to the
family. Arrestins from C. elegans and  C. intestinalis and
Kurtz in Drosophila seem to be ‘hybrids’: they are expressed
throughout the nervous system and support receptor inter-
nalization, similarly to the vertebrate non-visual arrestins,
yet participate in olfaction and vision, similarly to the
visual/sensory subtypes [4,5,16]. Thus, the first proto-
arrestins apparently emerged before the separation of the
main branches of eukaryotes. True arrestins in animals
evolved before the separation between the vertebrate and
invertebrate lineages and then diverged into visual and non-
visual groups early in the evolution of both lineages (Addi-
tional data file 1). 
Characteristic structural features 
Arrestins are ubiquitous (that is, every cell in animals has at
least one arrestin subtype) regulators of G-protein-coupled
receptors (GPCRs), the largest known family of signaling
proteins. Arrestins bind to the cytoplasmic side of active
phosphorylated forms of their cognate receptors, usually
engaging the carboxyl terminus and several cytoplasmic
loops of the receptor [1]. Arrestins shut off G-protein-medi-
ated signaling, target receptors to coated pits for internaliza-
tion and redirect GPCR signaling to a variety of
G-protein-independent pathways, such as the activation of
the protein tyrosine kinase Src, mitogen-activated protein
(MAP) kinase cascades, and so on [1,17]. The length of
arrestin proteins is fairly well conserved from C. elegans to
humans, in the range of 360-470 residues. 
Crystal structures of three out of the four subtypes of verte-
brate arrestins have been solved: bovine rod arrestin [8],
bovine arrestin2 [7] and salamander cone arrestin [9]. Each
of these arrestins is an elongated molecule with two domains
(amino-terminal and carboxy-terminal) and an extended
carboxy-terminal tail that makes a strong contact with the
body of the amino-terminal domain (Figure 2). The relative
orientation of the two domains in the basal conformation of
free arrestin in solution is supported by two characteristic
groups of intramolecular interactions or ‘clasps’ (Figure 2a).
Extensive mutagenesis studies indicate that both of these
clasps are unfastened by receptor-attached phosphates, so
that receptor binding induces a global conformational change
in arrestin [18]. This rearrangement involves the release of
the arrestin carboxy-terminal tail [19,20] and the movement
of the two domains relative to each other, which is limited by
the length of the inter-domain hinge [21]. The structures of
visual and non-visual arrestins from mammals and amphib-
ians show a remarkable conservation of overall fold [9]. Not
surprisingly, the key residues that stabilize the basal confor-
mation are conserved in all animal arrestins (Additional data
file 2). Extra sequences (sometimes up to 25-30 residues) in
the largest members of the family (such as Kurtz) are local-
ized at the amino and carboxy termini or in the loops between
putative   strands. Extra residues (including tags) added to
these elements of vertebrate arrestins do not compromise
their folding or functionality [22-24]. 
Each arrestin domain is an independent folding unit. Sepa-
rated domains are functional: the amino-terminal domain
preferentially binds active phosphoreceptors, albeit with lower
affinity than the full-length protein; the carboxy-terminal
domain does not [13,22]. Both domains bind microtubules
with even higher affinity than full-length arrestin [25]. The
arrestin fold was considered unique until a recent unex-
pected discovery of a very similar structure in Vps26 (vacuo-
lar protein sorting-associated protein 26, a subunit of the
retromer complex, which is involved in the recycling of the
sorting receptor from endosomes back to the Golgi) [26]. This
327-residue protein has two  -strand sandwich domains with
an arrestin-like design and relative orientation. The inter-
domain contact surface of Vps26, remarkably similar to that
of arrestins, includes an analog of the polar core and an
extensive set of hydrophobic interactions, even though
Vps26 has no detectable sequence homology with arrestin
family [26].     
Localization and function 
Arrestins are soluble, predominantly cytoplasmic proteins.
Binding to phosphorylated active GPCRs and termination of
G-protein-mediated signaling (receptor desensitization) was
the first arrestin function described. The ability of arrestins
to link GPCRs to the components of the internalization
machinery - clathrin [27] and AP2 [28] - was interpreted as a
natural extension of their desensitizing function. Subsequent
discoveries that receptor-bound arrestins interact with
numerous signaling proteins, linking GPCRs to a variety of
alternative signaling pathways (Table 3), put arrestins on an
equal footing with G proteins as a different class of signaling
adaptors recruited by active receptors [1,17]. The interaction
of arrestins and G proteins with overlapping sets of cytoplas-
mic receptor elements underlies their direct competition
[29], and in most cases receptor phosphorylation gives
arrestin an edge over G proteins [1]. 
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Figure 1 (see legend on the following page)
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Vertebrate cone arrestin
Vertebrate rod arrestin
Invertebrate sensory arrestins
Invertebrate non-sensory arrestins
Vertebrate arrestin3-like
Vertebrate arrestin3-like
Protochordate arrestin
Mammalian arrestin3
Mammalian arrestin2
L. migratoria arrestin
A. mellifera arrestin2
D. miranda arrestin2
L. polyphemus arrestin
H. virescens arrestin
A. macaronius arrestin1
A. gambiae arrestin1
A. gambiae arrestin2
A. gambiae arrestin Kurtz-like
G. gallus cone arrestin
H. sapiens cone arrestin
S. scrofa cone arrestin
B. taurus cone arrestin
M. musculus cone arrestin
S. tridecemlineatus cone arrestin
G. gecko arrestin
A. tigrinum cone arrestin
R. pipiens cone arrestin
X. laevis cone arrestin
D. rerio cone arrestin
O. latipes arrestin
H. sapiens rod arrestin
S. scrofa rod arrestin
C. familiaris rod arrestin
R. norvegicus rod arrestin
M. musculus rod arrestin
B. taurus rod arrestin
A. tigrinum rod arrestin
X. tropicalis rod arrestin
R. pipiens rod arrestin
O. latipes arrestin1
O. latipes arrestin2
M. musculus arrestin2
O. cuniculus arrestin2
H. sapiens arrestin3
H. sapiens arrestin2
M. musculus arrestin3
R. norvegicus arrestin3
R. norvegicus arrestin2
B. taurus arrestin3
B. taurus arrestin2
O. mykiss arrestin
D. rerio arrestin
X. laevis arrestin
C. intestinalis arrestin
C. elegans arrestin
C. vicina arrestin1
C. vicina arrestin2
D. melanogaster arrestin1
D. melanogaster arrestin2
D. melanogaster arrestin Kurtz
L. pealei arrestinReceptor-binding elements have been mapped to the
concave sides of both arrestin domains and the protruding
‘crest’ in the middle of the molecule that includes the ‘finger
loop’ between  -strands V and VI (Figure 2b) [20,30]. The
interaction sites of the proteins that bind the arrestin-recep-
tor complex must be localized on the non-receptor-binding
side of the molecule from this, or in the detachable arrestin
carboxy-terminal tail that is released by receptor binding.
The interaction sites of arrestin binding partners that are
recruited to the complex have never been properly mapped,
however, with the exception of clathrin and AP2, which bind
to the arrestin carboxy-terminal tail [31]. Arrestins interact
with the small G proteins ADP-ribosylation factor 6 (ARF6)
[32,33] and RhoA [34], their regulators ARNO (ARF
nucleotide binding site opener) [32,35] and the guanine-
nucleotide dissociation stimulator RalGDS [36], components
of MAP kinase cascades [37,38], c-Src and other non-recep-
tor tyrosine kinases [39-41], phosphodiesterase PDE4D [42]
and  others (Table 3). 
There is one common theme in the seemingly disparate func-
tions of these multi-faceted adaptors: arrestins bring proteins
together to make things happen. By interacting with several
partners simultaneously, arrestins orchestrate signaling in
space and time and direct enzymes to particular cellular com-
partments and substrates. Receptor-bound arrestins serve as
scaffolds for MAP kinase cascades, bringing together apopto-
sis signal-regulating kinase 1 (ASK1) and c-Jun N-terminal
kinase 3 (JNK3), as well as the kinase c-Raf-1 and extracellu-
lar signal-regulated kinase 2 (ERK2), thereby facilitating sig-
naling in the ASK1-Map kinase kinase 4 (MKK4)-JNK3 and
c-Raf-1-MAP/ERK kinase 1 (MEK1)-ERK2 pathways [37,38].
Curiously, arrestin3 also facilitates deactivation of JNK3 by
recruiting the dual-specificity phosphatase MKP7 [43]. When
ERK2 and JNK3 are activated by the arrestin-receptor
complex they stay bound and therefore remain in endosomes
and do not translocate to the nucleus [37,38]. Arrestins also
recruit ubiquitin ligases to the receptors: the E3 ubiquitin
ligase Mdm2 mobilized by mammalian non-visual arrestins
ubiquitinates GPCRs [44], and the E3 ligase Deltex mobi-
lized by Kurtz ubiquitinates the Notch receptor in
Drosophila [45]. Arrestin3 binds the multi-functional anti-
apoptotic protein kinase Akt (also known as protein kinase
B) and its negative regulator protein phosphatase 2A
(PP2A), facilitating deactivation of Akt in a manner depen-
dent on dopamine receptor stimulation [46]. Arrestin3 also
interacts directly with I B , an inhibitor of NF- B, prevent-
ing its phosphorylation and degradation and thereby modu-
lating the activity of NF- B [47]. Non-visual arrestins
regulate NF- B activity in another way, by interacting with
the tumor necrosis factor receptor-associated factor 6
(TRAF6) and preventing its autoubiquitination and activa-
tion of NF- B [48]. In addition to hundreds of GPCR sub-
types, arrestins also bind several membrane proteins that do
not belong to the GPCR superfamily and regulate their sig-
naling and/or trafficking (Table 3). These include the
insulin-like growth factor 1 receptor (IGF1R) [49], the type
III transforming growth factor-  (TGF )  receptor [50], the
low density lipoprotein (LDL) receptor [51] and  the Na+/H+
exchanger NHE5 [52].    
A dramatic conformational difference between free and
receptor-bound arrestin provides the structural basis for the
differential interaction of various binding partners with
these two functional forms of arrestin [1,53]. However, many
of the partners  believed to bind selectively to the arrestin-
receptor complex have been found to interact robustly with
free arrestins, for example, ARF6 [33], JNK3 [24,54] and
Mdm2 [24,55] (the latter even prefers arrestin ‘frozen’ in its
basal conformation [24]; Table 3). Some binding partners,
such as microtubules [25] and Ca2+-liganded calmodulin
[56], interact with the same surface of arrestin as is engaged
by the receptor; this means that they can interact only with
free arrestin and thus that they compete with GPCRs. The
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Figure 1 (see figure on the previous page)
A phylogenetic tree of the arrestin family. Amino-acid sequence alignments were performed using ClustalW in the MEGA3 software. The phylogenetic
tree was created using the neighbor-joining method (gap settings: pairwise deletions; distance method: number of differences). Numbers at selected
nodes indicate the percentage frequencies of branch associations on the basis of 1,000 bootstrap repetitions (all percentages over 50 are displayed).
Brackets on the right indicate subfamilies. The proteins included for each species, with accession numbers, are as follows: Ambystoma tigrinum (tiger
salamander) rod arrestin (AAF14636) and cone arrestin (AAF14637); Anopheles gambiae (African malaria mosquito) arrestin1 (AAG54081), arrestin2
(DAA00888) and Kurtz-like (DAA00889); Apis mellifera (honey bee) XP_623243 (predicted); Ascalaphus macaronius (neuropteran insect) CAC36938; Bos
taurus (cattle) rod arrestin (NP_851343), cone arrestin (BAA94344), arrestin2 (NP_776668) and arrestin3 (P32120): C. elegans (nematode) NP_508183;
Calliphora vicina (bluebottle fly) arrestin1 (P51486) and arrestin2 (P51487); Canis familiaris (dog) rod arrestin (NP_001003230); C. intestinalis (sea squirt)
BAB60819; Danio rerio (zebrafish) cone arrestin (NP_001002405) and arrestin3 (NP_957418); D. melanogaster (fruit fly) arrestin1 (NP_476681), arrestin2
(NP_523976) and Kurtz (NP_524988); Drosophila miranda (fruit fly) arrestin2 (P19108); Gallus gallus (chicken) cone arrestin (XP_420156, predicted);
Gekko gecko (tokay) cone arrestin (AAQ94621); Heliothis virescens (tobacco budworm) AAB25861; Homo sapiens (human) rod arrestin (NP_000532),
cone arrestin (AAB84302), arrestin2 (NP_004032 isoform A) and arrestin3 (NP_004304 isoform 1); Limulus polyphemus (Atlantic horseshoe crab)
P51484; Locusta migratoria (migratory locust, insect) P32122; Loligo pealei (squid) AAK84368; Mus musculus (mouse) rod arrestin (AAH16498), cone
arrestin (AAG38954), arrestin2 (NP_796205 isoform A) and arrestin3 (NP_663404); Oncorhynchus mykiss (rainbow trout) arrestin (P51466); Oryctolagus
cuniculus (rabbit) arrestin2 (AAC48753); Oryzias latipes (killifish) rod1 arrestin (BAA82259), rod2 arrestin (BAA21718) and cone arrestin (BAA21719);
Rana pipiens (northern leopard frog) rod (CAA63135) and cone (CAA63137); Rattus norvegicus (rat) rod (NP_037155), arrestin2 (NP_037042) and
arrestin3 (NP_037043); Spermophilus tridecemlineatus (squirrel) cone arrestin (AAS89816); Sus scrofa (pig) rod arrestin (NP_999244) and cone arrestin
(NP_999510); Xenopus laevis (frog) cone arrestin (AAH94203) and arrestin3-like (AAH76815); and Xenopus tropicalis rod arrestin (NP_989073).  fact that the affinity of arrestin for GPCRs is in the sub-
nanomolar range [13] and that for microtubules [25] and
calmodulin [56] is in the micromolar range suggest that the
active phosphorylated receptor always wins, but other func-
tional forms of the receptor might not. Indeed, competition
between rhodopsin and microtubules has recently been
shown to underlie the dramatic redistribution of rod arrestin
in light- and dark-adapted photoreceptors in vivo [57]. 
The expression of rod and cone arrestins is limited to their
respective photoreceptor types in the retina, although both
are also present in pinealocytes. The intracellular concentra-
tion of rod arrestin in rod photoreceptors is enormous (over
100  M) [58]. Virtually every mammalian cell expresses
both non-visual arrestins [11,59]. Non-visual arrestins are
certainly present in mouse neural precursors at embryonic
day 12 [15], but given that arrestins have a role in the early
development of zebrafish, in which functional knockdown of
arrestin3 recapitulates the phenotypes of Hedgehog pathway
mutants [60], arrestins are probably expressed much earlier
in development. From C. elegans to mammals, the highest
expression levels of non-visual arrestins are found in neurons
[5,15,61]. In rat neural precursors, arrestin2 and arrestin3 are
expressed at comparable levels (approximately 30 nM).
During neural development the expression of arrestin2
mRNA and protein increases dramatically, so that in mature
neurons arrestin2 predominates, with intracellular concen-
trations reaching approximately 200 nM (compared with
about 10 nM of arrestin3) [15]. There are neuronal types,
however, that express arrestin3 almost exclusively, such as
olfactory epithelial cells [15].  
Both mammalian visual arrestins and arrestin3 are predomi-
nantly cytoplasmic, whereas the subcellular distribution of
arrestin2 varies: for example, it is more abundant in the
cytoplasm of striatal neural precursors and neurons and
mostly nuclear in the pyramidal neurons [15,24]. Although
they do not have identifiable nuclear localization sequences
and only arrestin3 has a recognizable nuclear export signal
in its carboxy-terminal tail, all mammalian arrestins enter
the nucleus and can be exported by different pathways
[24,54,55]. In the process of export, they remove their inter-
action partners JNK3 and Mdm2 from the nucleus
[24,54,55]. The subtype that is found most often in the
nucleus, arrestin2, has a role in the regulation of histone
acetylation and gene transcription [62].
Knockout of Kurtz, the only non-sensory arrestin in
Drosophila, is embryonically lethal, as is the simultaneous
knockout of both non-visual arrestins in mice [61,63],
whereas mice lacking either arrestin2 or arrestin3 are
grossly normal [63]. Thus, a functional non-visual arrestin is
indispensable for normal development, but the two mam-
malian subtypes can serve as backups for one another. Prob-
ably for this reason, no human disorder associated with the
loss of function of either non-visual arrestin has been
described so far. The loss of rod arrestin underlies a form of
congenital night blindness, Oguchi disease [64]. 
Considering the number of arrestin interaction partners that
participate in life-and-death decisions in cells (such as Src,
ASK1, c-Raf-1, ERK2, JNK3, Mdm2, Akt and I B ), it is
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Figure 2 
Key structural elements of arrestin proteins. This model of a generic
arrestin molecule was generated in ViewerPro using the crystal structures
of bovine rod arrestin [8] and arrestin2 [7]. The proximal carboxy-
terminal tail (dark gray) missing in the structures has been modeled
arbitrarily. (a) Intra-molecular interactions holding arrestin in the basal
conformation. The structure is shown in ribbon representation, except
for the residues in the polar core (blue, positive charges; red, negative
charges) and the hydrophobic residues in the three-element interaction
(yellow), which are shown in space-filling representation. Dark gray
indicates the carboxy-terminal tail; magenta, the lariat loop in the
carboxy-terminal domain containing two polar core negative charges; light
brown, the inter-domain hinge (at the back of the molecule). The polar
core is a cluster of five virtually solvent-excluded charged residues, which
is unusual for a soluble protein; it includes one negative and one positive
charge in the amino-terminal domain, two negative charges in the lariat
loop of the carboxy-terminal domain and one positive charge in the
carboxy-terminal tail. The three-element interaction is mediated by
clusters of bulky hydrophobic residues in  -strand I,  -helix I and the
carboxy-terminal tail. (b) Known interaction sites on the arrestin
molecule. Receptor-binding elements: blue, positive charges that bind
receptor-attached phosphates [70]; yellow, hydrophobic residues in
 -strand X [71]; green, elements that determine receptor specificity [30].
Other elements: magenta, the clathrin-binding element in the proximal
carboxy-terminal tail [27]; red, AP2-binding residues in the distal carboxy-
terminal tail [28].c
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Table 3
Arrestin binding partners
Arrestin conformation†
Binding proteins* Arrestin subtype GPCR-bound Free Function References
Trafficking proteins
Clathrin Arrestin2, arrestin3 +++ + Endocytosis [27]
AP-2 Arrestin2, arrestin3 +++ + Endocytosis [28]
NSF Arrestin2 + + Endocytosis, recycling [72]
Small G proteins and guanyl nucleotide exchange factors
ARF6 Arrestin3, arrestin2 +++ +++ Endocytosis, docking [32,33]
ARNO Arrestin3 +++ +++ Endocytosis [32,33]
RalGDS Arrestin2, arrestin3 ? +++ Ral-mediated cytoskeleton reorganization [36]
RhoA Arrestin2 ? ? Angiotensin II-dependent stress fiber formation [34]
MAP kinase cascade components
ASK1 Arrestin3 +++ ? JNK3 and p38 activation [38]
c-Raf-1 Arrestin2, arrestin3 +++ ? ERK activation [37]
JNK3 Arrestin2, arrestin3,  +++ +++ Stabilization of phosphorylated (active)  [24,38,54]
rod arrestin, cone arrestin  JNK on endosomes; export of phosphorylated 
(active) JNK from the nucleus 
ERK2 Arrestin2, arrestin3 +++ ? Stabilization of phosphorylated (active) ERK  [37]
on endosomes
Non-receptor tyrosine kinases
c-Src Arrestin2, arrestin3 +++ ? Endocytosis, ERK activation [39]
Yes Arrestin2 +++ ? G q activation and GLUT4 transport [41]
Hck Arrestin2 +++ ? Exocytosis of granules in neutrophils [40]
Fgr Arrestin2 +++ ? Exocytosis of granules in neutrophils [40]
Non-GPCR membrane proteins
Na+/H+ exchanger NHE5 Arrestin2, arrestin3 ? + Trafficking [52]
IGF I receptor  Arrestin2, arrestin3 ? + Trafficking [49]
LDL receptor Arrestin3 ? + Trafficking [51]
TGF-  receptor type III  Arrestin3 ? + Trafficking [50]
TrkA receptor Arrestin2 ? + Endocytosis, MAPK activation [73]
Other
Mdm2 Arrestin2, arrestin3,  ++ +++ Receptor ubiquitination, endocytosis,  [24,44,55]
rod arrestin, cone arrestin export of Mdm2 from the nucleus
Deltex Drosophila Kurtz  ? + Degradation of Notch receptor [45]
I B  Arrestin2, arrestin3 +++ + Stabilization of I B ,  2AP and TNFR stimulation [47,74]
PDE4D family Arrestin2, arrestin3 +++ ? cAMP degradation [42]
PP2A Arrestin2 +++ +++ Ser412 dephosphorylation [46]
MKP7 Arrestin2, arrestin3 +++ ? Dephosphorylation [43]
Akt Arrestin2, arrestin3 +++ ? Dephosphorylation [46]
Microtubules Arrestin2, arrestin3,  - +++ Subcellular localization [75]
rod arrestin, cone arrestin
Dishevelled Arrestin2, arrestin3 ? + Transcription regulation, endocytosis of Frizzled4 [76,77]
TRAF6 Arrestin3 ? ? Regulation of TLR-IL-1R signaling  [48]
Histone acetyltransferase  Arrestin2 ? +++ Regulates histone H4 acetylation and  [62]
p300 activity of p27 and c-fos promoters
Calmodulin (with Ca2+) Arrestin2, arrestin3,  - +++ Ca2+ signaling? [56]
rod and cone arrestin
Small molecules
Phosphoinositides Arrestin2, arrestin3,  +++ +++ Endocytosis, light-dependent translocation of  [78,79]
Drosophila arrestin-2  Drosophila arrestin2 in photoreceptors 
Inositol phosphates Rod arrestin,  - +++ Arrestin oligomerization, inhibition of  [80,81]
arrestin2, arrestin3 receptor binding
*This table includes only arrestin binding partners that are not GPCRs. For a list of GPCRs that have been shown to interact with arrestins, see [1].
Abbreviations: Fgr, a Src-family member; GLUT4, glucose transporter 4; Hck, hematopoietic cell kinase; IL-1R, interleukin 1 receptor; NSF, N-ethylmaleimide-
sensitive factor; TLR, Toll-like receptor; TrkA receptor, nerve growth factor receptor; Yes, a Src-family member. †The binding of the partners to
different conformational states of arrestin is designated, as follows: +, binds; +++, binds with high-affinity; ?, not known.hardly surprising that arrestins have a role in cell death and
survival. The effects of arrestin vary with the system,
however. Stable arrestin-rhodopsin complexes in Drosophila
photoreceptors induce apoptosis [65,66], and the complex of
arrestin2 and the receptor for the neuropeptide substance P
induces non-apoptotic programmed cell death through acti-
vation of ERK2 and phosphorylation of the nuclear receptor
Nur77 [67]. By contrast, arrestins promote activation of
phosphatidylinositol 3-kinase that is dependent on the
insulin-like growth factor receptor and has an anti-apoptotic
effect [68], and they block GPCR-mediated apoptosis [69].
The mechanisms of arrestin-mediated cell death and sur-
vival remain to be elucidated.
Frontiers 
As far as the origins and evolution of arrestins are con-
cerned, several questions remain. First, did the arrestin
domains, which can fold independently, emerge indepen-
dently? Thus far there is no known protein that has only one
of these domains; even the ‘third cousins’ in fungi and pro-
tists have homologs of both domains in the right order.
Second, do plants have arrestins? Plants are the only large
group of eukaryotes in which no arrestin-like proteins have
been described. Their discovery may help to answer the first
question. Third, is arrestin2 really a mammalian invention,
or is it simply by chance that no close relatives have been
cloned from lower vertebrates?
From a structural standpoint, the most important piece that
is missing from the puzzle is the structure of ‘active’, recep-
tor-bound arrestin. We have high-resolution crystal struc-
tures of three arrestins in the basal conformation, as well as
three structures of the inactive prototypical GPCR,
rhodopsin, but these are the functional states of these two
proteins in which they do not interact. Proposed models of
the arrestin-receptor complex [17,18] are derived from a lot
of indirect evidence, but they are educated guesses, not the
real thing. The structure of the complex would answer bio-
logically important questions regarding its stoichiometry.
The shape of the complex would shed light on its scaffolding
functions and explain why its formation facilitates signaling
in so many pathways. We do not even know whether there is
just one specific conformation of arrestin in the complex, or
whether arrestin can assume a whole family of active confor-
mations once the clasps holding it in the basal state are
released by the receptor, as some experimental evidence
suggests [1]. Microtubule-bound arrestin assumes yet
another conformation, distinct from that of the free and
receptor-bound forms [25], but we know almost nothing
about the functional capabilities of this state of arrestin.
Several laboratories using a wide variety of methods have
mapped arrestin elements involved in receptor binding, so
that we know exactly which side of the molecule faces the cyto-
plasmic tip of the receptor. The ‘footprints’ of microtubules
[25] and calmodulin [56] on the body of the arrestin molecule,
and the relatively small clathrin- and AP2-binding sites in the
arrestin carboxy-terminal tail [31] have been identified with
reasonable precision. The interaction sites for the great
majority of the non-receptor binding partners have been
localized very imprecisely or not at all, however. With very
few exceptions, we do not know whether some signaling pro-
teins prefer a single arrestin conformation out of the three
known ones, let alone which partners bind preferentially to
which functional state of arrestin. In addition, the very
modest size of arrestins (40-45 kDa), along with the enor-
mous number of known binding partners of similar or greater
size, strongly suggests that arrestin in any conformation
cannot interact with them all simultaneously. Thus, certain
groups of arrestin partners must compete with each other for
the overlapping binding sites. Which proteins can ‘share’
arrestin because their binding sites are far enough from each
other, which partners compete, how this competition is regu-
lated, and what factors determine the ‘winners’ are the key
questions that need to be addressed experimentally.
In summary, we know that arrestins do a lot more than
simply block binding of G proteins to active receptors.
Arrestins are multi-functional regulators at the crossroads of
multiple signaling pathways. The next challenge is to under-
stand the fine molecular mechanisms of their functional
interactions with an incredible variety of signaling proteins.
These studies have clear therapeutic potential as they will
provide a firm foundation for the targeted manipulation of
arrestin function.
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tional data file 2 is a figure showing an alignment of arrestin
sequences.
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